US FDA Approves New Oral Thalassemia Drug; Dr Sanjeev Bagai Calls It ‘Game Changer’ | India Today
In a major medical breakthrough, the US FDA has approved a new oral drug for Thalassemia, offering hope for a transfusion-free life. Discussing the development, Dr Sanjeev Bagai, Chairman of Nephron Clinic, states that the...